Polymer-Protein Conjugates
-10%
portes grátis
Polymer-Protein Conjugates
From Pegylation and Beyond
Pasut, Gianfranco; Zalipsky, Samuel
Elsevier Science & Technology
10/2019
512
Mole
Inglês
9780444640819
15 a 20 dias
Descrição não disponível.
Introduction and General Aspects of the Technology 1. Evolution of Polymer Conjugation to proteins 2. PEGylated Proteins: A Rational Design for Mitigating Clearance Mechanisms and Altering Biodistribution 3. Overcoming barriers for tumor-targeted drug delivery: the power of macromolecular anticancer drugs with the EPR effect and the modulation of vascular physiology Toxicity and Immunogenicity Studies and Clinical Stage Conjugate Products 4. PEG-protein conjugates: Non-clinical and clinical toxicity considerations 5. Immunological responses to PEGylated proteins: anti-PEG antibodies 6. Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study 7. PEG-Protein conjugates: regulatory requirements for characterization 8. PEGylation of human coagulation factor VIII and other plasma proteins 9. Pegvorhyaluronidase Alfa: A PEGylated Recombinant Human Hyaluronidase PH20 for the Treatment of Cancers That Accumulate Hyaluronan 10. Challenges in the analytical characterization of PEGylated asparaginases Novel Site-Selective Methods of Conjugation 11. Glycan-targeted PEGylation for selective modification of proteins 12. Sialyltransferase mediated glycoPEGylation 13. Enzymatic approaches to new protein conjugates 14. Site-specific Polymer-protein conjugates by Cys mutation 15. Site-specific PEGylation of interferon beta-1b: from bench to clinic 16. Protein modification by bis-alkylation Alternative non-PEG polymers and architectures 17. In vivo properties of therapeutic bioconjugates composed of proteins and architecturally/functionally complex polymers 18. Poly(2-oxazoline)-protein conjugates 19. Polysaccharides for protein and peptide conjugation 20. Polysialylation of human coagulation factor VIII
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Introduction and General Aspects of the Technology 1. Evolution of Polymer Conjugation to proteins 2. PEGylated Proteins: A Rational Design for Mitigating Clearance Mechanisms and Altering Biodistribution 3. Overcoming barriers for tumor-targeted drug delivery: the power of macromolecular anticancer drugs with the EPR effect and the modulation of vascular physiology Toxicity and Immunogenicity Studies and Clinical Stage Conjugate Products 4. PEG-protein conjugates: Non-clinical and clinical toxicity considerations 5. Immunological responses to PEGylated proteins: anti-PEG antibodies 6. Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study 7. PEG-Protein conjugates: regulatory requirements for characterization 8. PEGylation of human coagulation factor VIII and other plasma proteins 9. Pegvorhyaluronidase Alfa: A PEGylated Recombinant Human Hyaluronidase PH20 for the Treatment of Cancers That Accumulate Hyaluronan 10. Challenges in the analytical characterization of PEGylated asparaginases Novel Site-Selective Methods of Conjugation 11. Glycan-targeted PEGylation for selective modification of proteins 12. Sialyltransferase mediated glycoPEGylation 13. Enzymatic approaches to new protein conjugates 14. Site-specific Polymer-protein conjugates by Cys mutation 15. Site-specific PEGylation of interferon beta-1b: from bench to clinic 16. Protein modification by bis-alkylation Alternative non-PEG polymers and architectures 17. In vivo properties of therapeutic bioconjugates composed of proteins and architecturally/functionally complex polymers 18. Poly(2-oxazoline)-protein conjugates 19. Polysaccharides for protein and peptide conjugation 20. Polysialylation of human coagulation factor VIII
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
